Bristol-Myers Squibb
BMY
#169
Rank
S$151.38 B
Marketcap
S$74.34
Share price
-2.12%
Change (1 day)
-4.68%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2025 (TTM): S$3.89

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is S$3.80. In 2024 the company made an earnings per share (EPS) of S-$5.65 a decrease over its 2023 EPS that were of S$4.96.

EPS history for Bristol-Myers Squibb from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$3.89-168.74%
2024S-$5.65-213.92%
2023S$4.9630.2%
2022S$3.81-6.04%
2021S$4.06-179.29%
2020S-$5.12-281.37%
2019S$2.82-27.21%
2018S$3.88
2016S$3.42175.26%
2015S$1.24-19.83%
2014S$1.55-22.44%
2013S$2.0034.48%
2012S$1.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$14.25 275.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$9.42 147.81%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$1.74-54.21%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$3.06-19.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$29.45 675.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$18.33 382.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$2.64-30.47%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
S$14.06 270.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$9.35 146.02%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$6.84 80.13%๐Ÿ‡ฌ๐Ÿ‡ง UK